logo

Fibrogen Inc. (FGEN)



Trade FGEN now with
  Date
  Headline
8/11/2020 7:18:24 AM FibroGen Says First Patient Enrolled In Pamrevlumab Phase 3 Clinical Trial
6/23/2020 7:13:39 AM FibroGen Begins Phase 2 Study Investigating The Efficacy And Safety Of Pamrevlumab In Patients With Acute COVID-19
6/8/2020 7:28:45 AM FibroGen Says First Patient Enrolled In Pamrevlumab Clinical Trial In Patients With Severe COVID-19
5/20/2020 10:56:29 PM European Medicines Agency Accepts Astellas' Marketing Authorization Application For Roxadustat
4/20/2020 7:15:56 AM FibroGen Says Disappointed With UK Court's Decision
3/2/2020 4:05:53 PM FibroGen Q4 Loss/share $1.12 Vs. Profit $0.23 Year Ago
2/11/2020 5:18:36 PM FibroGen Announces FDA Acceptance Of NDA For Roxadustat For Treatment Of Anemia Of Chronic Kidney Disease
1/30/2020 12:10:03 AM Astellas Submits SNDA For Approval Of Evrenzo For Anemia Associated With CKD In Non-Dialysis Dependent Patients In Japan
1/6/2020 7:14:32 AM FibroGen Appoints Enrique Conterno As CEO And Member Of Board
12/23/2019 7:11:08 AM FibroGen Submits NDA For Roxadustat In Patients With Anemia Of Chronic Kidney Disease
11/5/2019 10:33:29 PM Duke Realty Announces Pricing Terms For $400 Mln Senior Unsecured Notes Offering
9/26/2019 7:14:37 AM FibroGen Says First Patient Dosed In Phase 2 Clinical Study Of Roxadustat
9/20/2019 3:10:45 AM X5 Retail Announces Opening Of First New-concept Pyaterochka Store
9/20/2019 3:01:37 AM Evrenzo Tablets Approved In Japan For Anemia Associated With Chronic Kidney Disease In Dialysis Patients